LBA-3, a selective and orally active inhibitor of the sodium-coupled citrate transporter SLC13A5, exhibits an IC50 of 67 nM. This compound effectively reduces triglyceride and total cholesterol levels in both oleic and palmitic acid (OPA)-stimulated AML12 cells and PCN-stimulated primary mouse hepatocytes, as well as in mouse models, without showing detectable toxicity. Additionally, LBA-3 is permeable to the blood-brain barrier [1].
Molecular Weight:
314.33
CAS Number:
[2918263-09-7]
Formula:
C18H18O5
Target:
Sodium Channel
T86803
* VAT and and shipping costs not included. Errors and price changes excepted
